Children's cancers, Neuroblastoma
Results
Phase 1
This trial looked at using white blood cells called anti-GD2 T cells to treat neuroblastoma. It was for people aged 12 months or older, whose cancer had not responded to treatment or had come back after treatment.
The trial was supported by Cancer Research UK. It was open for people to join between 2016 and 2019. The team reported the results in 2021.
Recruitment start: 26 February 2016
Recruitment end: 31 October 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor John Anderson
Cancer Research UK (Centre for Drug Development)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/15/001.
Last reviewed: 22 December 2021
CRUK internal database number: 9177
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
